Rex Neal Smith, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 11 | 2023 | 4251 | 0.820 |
Why?
|
| Isoantibodies | 5 | 2018 | 679 | 0.730 |
Why?
|
| Graft Rejection | 11 | 2023 | 4397 | 0.710 |
Why?
|
| Dyspnea | 1 | 2023 | 1303 | 0.520 |
Why?
|
| Graft Survival | 11 | 2019 | 3737 | 0.470 |
Why?
|
| Transplantation Tolerance | 3 | 2019 | 617 | 0.410 |
Why?
|
| Macaca fascicularis | 7 | 2019 | 915 | 0.380 |
Why?
|
| Complement C4b | 1 | 2005 | 135 | 0.260 |
Why?
|
| Transplantation, Homologous | 7 | 2023 | 4776 | 0.250 |
Why?
|
| Transplantation Chimera | 4 | 2019 | 612 | 0.240 |
Why?
|
| Vascular Diseases | 2 | 2022 | 1161 | 0.240 |
Why?
|
| Heart Transplantation | 4 | 2013 | 3110 | 0.200 |
Why?
|
| Transplantation, Heterologous | 3 | 2017 | 2382 | 0.200 |
Why?
|
| Formaldehyde | 1 | 2023 | 353 | 0.200 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2002 | 288 | 0.190 |
Why?
|
| Bone Marrow Transplantation | 3 | 2019 | 2765 | 0.170 |
Why?
|
| Vasculitis | 1 | 2002 | 519 | 0.160 |
Why?
|
| Transplantation Conditioning | 3 | 2018 | 1598 | 0.160 |
Why?
|
| Kidney Diseases | 2 | 2006 | 2149 | 0.160 |
Why?
|
| Histocompatibility | 1 | 2018 | 330 | 0.140 |
Why?
|
| Biopsy | 3 | 2023 | 6756 | 0.140 |
Why?
|
| Liver Failure, Acute | 1 | 2017 | 165 | 0.130 |
Why?
|
| Cell Transplantation | 1 | 2017 | 477 | 0.130 |
Why?
|
| Coronary Vessels | 1 | 2005 | 3107 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 2005 | 5097 | 0.110 |
Why?
|
| Papio | 2 | 2014 | 656 | 0.110 |
Why?
|
| Organ Transplantation | 1 | 2022 | 1139 | 0.100 |
Why?
|
| Receptors, Chemokine | 2 | 2006 | 669 | 0.100 |
Why?
|
| Immunosuppressive Agents | 3 | 2018 | 4149 | 0.100 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 413 | 0.090 |
Why?
|
| Pneumonia | 1 | 2022 | 2133 | 0.090 |
Why?
|
| Immune Tolerance | 4 | 2018 | 2258 | 0.090 |
Why?
|
| Hepatocytes | 1 | 2017 | 1211 | 0.090 |
Why?
|
| Kidney | 2 | 2023 | 7186 | 0.090 |
Why?
|
| Stem Cell Factor | 1 | 2010 | 219 | 0.090 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 935 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2010 | 227 | 0.080 |
Why?
|
| Galactosyltransferases | 1 | 2010 | 263 | 0.080 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2004 | 745 | 0.080 |
Why?
|
| Swine | 3 | 2017 | 5917 | 0.080 |
Why?
|
| Haplorhini | 1 | 2008 | 552 | 0.080 |
Why?
|
| Selectins | 1 | 2007 | 102 | 0.080 |
Why?
|
| CD40 Ligand | 2 | 2010 | 526 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 648 | 0.070 |
Why?
|
| Running | 1 | 2012 | 480 | 0.070 |
Why?
|
| Muromonab-CD3 | 1 | 2005 | 96 | 0.070 |
Why?
|
| Apyrase | 1 | 2007 | 364 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 791 | 0.060 |
Why?
|
| Skin Transplantation | 1 | 2010 | 1074 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2019 | 13033 | 0.060 |
Why?
|
| Boronic Acids | 1 | 2009 | 965 | 0.060 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2004 | 48 | 0.060 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2012 | 1541 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2014 | 2119 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2005 | 566 | 0.050 |
Why?
|
| Pyrazines | 1 | 2009 | 1230 | 0.050 |
Why?
|
| Capillaries | 1 | 2005 | 773 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2008 | 9146 | 0.050 |
Why?
|
| Animals | 16 | 2019 | 168757 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2002 | 428 | 0.050 |
Why?
|
| Heart Arrest | 1 | 2012 | 1470 | 0.050 |
Why?
|
| T-Lymphocytes | 3 | 2011 | 10180 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 2505 | 0.050 |
Why?
|
| Pancreas | 1 | 2007 | 1686 | 0.050 |
Why?
|
| Pancreatitis | 1 | 2007 | 1092 | 0.050 |
Why?
|
| Young Adult | 3 | 2023 | 56430 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2751 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2022 | 675 | 0.040 |
Why?
|
| Antibodies | 2 | 2022 | 2460 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2006 | 1026 | 0.040 |
Why?
|
| GATA3 Transcription Factor | 1 | 2019 | 157 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2002 | 1475 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2007 | 2240 | 0.040 |
Why?
|
| Myocardium | 2 | 2013 | 4776 | 0.040 |
Why?
|
| Papio hamadryas | 1 | 2017 | 29 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2014 | 1549 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2007 | 4026 | 0.040 |
Why?
|
| Humans | 10 | 2023 | 744343 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 2019 | 936 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2017 | 961 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2017 | 644 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2005 | 2148 | 0.030 |
Why?
|
| Microspheres | 1 | 2017 | 777 | 0.030 |
Why?
|
| Histocompatibility Testing | 2 | 2009 | 741 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2019 | 1200 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2018 | 1057 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 1613 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 2014 | 355 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 2007 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2007 | 6386 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 9274 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 14722 | 0.020 |
Why?
|
| Cell Separation | 1 | 2017 | 1751 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 5 | 2007 | 21827 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2002 | 2133 | 0.020 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 18029 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 2988 | 0.020 |
Why?
|
| Leukapheresis | 1 | 2010 | 131 | 0.020 |
Why?
|
| Female | 6 | 2023 | 380194 | 0.020 |
Why?
|
| Disease Progression | 1 | 2006 | 13284 | 0.020 |
Why?
|
| Chimerism | 1 | 2010 | 158 | 0.020 |
Why?
|
| Models, Animal | 2 | 2006 | 2171 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 11366 | 0.020 |
Why?
|
| Splenectomy | 1 | 2010 | 395 | 0.020 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2010 | 272 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2002 | 3336 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2014 | 1301 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 6489 | 0.020 |
Why?
|
| Antilymphocyte Serum | 1 | 2009 | 492 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2013 | 851 | 0.020 |
Why?
|
| Mice | 6 | 2017 | 81183 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2010 | 795 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1179 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2006 | 517 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6538 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 693 | 0.020 |
Why?
|
| Genotype | 1 | 2019 | 12951 | 0.020 |
Why?
|
| Receptors, CXCR3 | 1 | 2006 | 237 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 4479 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2011 | 1348 | 0.020 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2004 | 59 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2009 | 652 | 0.020 |
Why?
|
| Male | 9 | 2017 | 350118 | 0.010 |
Why?
|
| Lung | 1 | 2022 | 9856 | 0.010 |
Why?
|
| L-Selectin | 1 | 2004 | 213 | 0.010 |
Why?
|
| Epitopes | 1 | 2010 | 2571 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2009 | 1381 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2013 | 4199 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2004 | 212 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 1265 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2618 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 1602 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2007 | 834 | 0.010 |
Why?
|
| Fibrosis | 1 | 2007 | 2029 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1641 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2011 | 5974 | 0.010 |
Why?
|
| Glucagon | 1 | 2002 | 533 | 0.010 |
Why?
|
| Time Factors | 2 | 2018 | 40075 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2505 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1678 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2002 | 1827 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 1836 | 0.010 |
Why?
|
| Chemokines | 1 | 2004 | 970 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2009 | 1786 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3870 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2004 | 2008 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2006 | 1738 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2004 | 1061 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4982 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4751 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 2478 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 77449 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2002 | 1878 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2004 | 986 | 0.010 |
Why?
|
| Sex Factors | 1 | 2012 | 10397 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15076 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6365 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2013 | 4584 | 0.010 |
Why?
|
| RNA | 1 | 2006 | 2749 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 4665 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 20947 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 25625 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2014 | 15295 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 10481 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39050 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 35136 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 41006 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 40561 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 7322 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2004 | 14557 | 0.010 |
Why?
|
| Insulin | 1 | 2002 | 6580 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2004 | 11483 | 0.000 |
Why?
|
| Adult | 2 | 2012 | 214055 | 0.000 |
Why?
|
| Child | 1 | 2013 | 77709 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 85781 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 72290 | 0.000 |
Why?
|
| United States | 1 | 2012 | 69872 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2009 | 63114 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2004 | 23403 | 0.000 |
Why?
|
| Aged | 1 | 2012 | 163280 | 0.000 |
Why?
|
| Middle Aged | 1 | 2012 | 213383 | 0.000 |
Why?
|